One of the micro-cap stocks engaged in manufacturing pharmaceutical ingredients and antacid molecules. The stock has skyrocket by 12.63 percent after reporting a revenue increase of 53.31% QOQ and 33.88% YOY, and net profit increased by 239.34% QOQ and 75.72% YOY.
Share Price Movement
After announcing its quarterly results, Par Drugs and Chemicals Limited’s share has skyrocket by 12.63 percent from the previous close of Rs. 266.56. The stock opened at Rs 305 and is currently trading at Rs 300.22, with a high of Rs. 312 and a low of Rs 281. The market capitalization now stands at approximately Rs. 369.41 crore.
What Happened
Par Drugs and Chemicals Limited’s recent quarter, which saw a rise in revenue and net profits, was the reason for the bullish movement in the stock price. According to its recent filing, in the quarter ending September 2024, Par Drugs and Chemicals Limited’s revenue from operations has increased by 33.88 percent YOY, from Rs. 25.89 crore in Q2 FY24 to Rs. 34.66 crore in Q2 FY25, and grown by 53.31 percent QoQ from Rs. 22.61 crore in Q1 FY25.
The company’s net profit has increased by 75.72 percent, from Rs. 4.89 crore in Q2 FY24 to Rs. 8.6 crore in Q2 FY25. As compared to the last quarter of 2025, the company’s net profit is up by 239.34 percent QoQ from Rs. 2.53 crore.
Par Drugs and Chemicals Limited’s EPS has increased by 76.07 percent from Rs. 3.97 in Q2 FY24 to Rs. 6.99 in Q2 FY25. As compared to the last quarter of 2025, the company’s EPS is up by 239.32 percent QoQ from Rs. 2.06 crore. The EBITDA margin has improved by 55% YOY.
In terms of return ratios, Par Drugs and Chemicals Limited’s share ROE and ROCE are currently at 18.5 percent and 25 percent, respectively. Par Drugs and Chemicals Limited is a debt-free company, which has maintained a total borrowing zero in FY24
Also read…
Shareholding Pattern
As of the September 2024 shareholding pattern, Par Drugs and Chemicals Limited has majorly held a promoter by 73.37 percent, a foreign institutional investor by 0.09 percent, and the public by 26.54 percent.
About the Company
Par Drugs and Chemicals Limited was established in 1982 in Bhavnagar, Gujarat, and specializes in manufacturing active pharmaceutical ingredients and antacid molecules. The company operates four manufacturing blocks with a total capacity of 9,700 metric tons annually. Under the leadership of Jignesh and Falgun Savani, Par Drugs delivers products to domestic and international markets.
The company produces a diverse range of products, including magnesium hydroxide, aluminum hydroxide gel, and silicon dioxide for pharmaceutical applications. Par Drugs converted from a private to a public entity in 2018, marking a significant milestone in its growth journey. The company’s manufacturing facility in Gujarat serves as the primary hub for producing bulk drugs and active ingredients.
Written By – Nikhil Naik
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
Start Your Stock Market Journey Today!
Want to learn Stock Market trading and Investing? Make sure to check out exclusive Stock Market courses by FinGrad, the learning initiative by Trade Brains. You can enroll in FREE courses and webinars available on FinGrad today and get ahead in your trading career. Join now!!
